Consumers and providers - Could they make better use of antibiotics?

International Journal of Risk and Safety in Medicine

Volumn 17, Issue 3-4, 2005, Pages 117-125

  Nordberg, Per ^a   Stålsby Lundborg, Cecilia ^b   Tomson, Göran ^b  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; CONSUMER; COST CONTROL; DRUG COST; DRUG EFFICACY; DRUG MARKETING; DRUG USE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; REIMBURSEMENT; REVIEW;

EID: 27744456888     PISSN: 09246479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. L. Bavestrello and A. Cabello, Impact of regulatory measures on antibiotic sales in Chile, in: International Conference on Improving Use of Medicines, Abstract ID: AM003.
2. W.K. Bosu, Survey of antibiotic prescribing pattern in government health facilities of the Wassa west district of Ghana, East African Medical Journal 74 (1997), 138-142.
3. C. Cederlöf and G. Tomson, Private pharmacies and the health sector reform in developing countries - professional and commercial highlights, Journal of Social and Administrative Pharmacy 12 (1995), 101-111.
4. J. Chalker, S. Ratanawijitrasin, N.T. Chuc, M. Petzold and G. Tomson, Effectiveness of a multi-component intervention on dispensing practices at private pharmacies in Vietnam and Thailand - a randomised controlled trial, Social Science and Medicines 60(1) (2005), 131-141.
5. J. Chalker, N.T.K. Chuc, T. Falkenberg, N.T. Do and G. Tomson, STD management by private pharmacies in Hanoi: practise and knowledge of drug sellers, Sexually Transmitted Infections 35 (2000), 299-302.
6. N.T.K. Chuc, M. Larsson, N.T. Do, K.V. Diwan, G. Tomson and T. Falkenberg, Improving private pharmacy practice: a multi-intervention experiment in Hanoi, Vietnam, Journal of Clinical Epidemiology 55(11) (2002), 1148-1155.
7. N.T.K. Chuc, M. Larsson, T. Falkenberg, N.T. Do, N.T. Binh and G. Tomson, Management of childhood acute respiratory infections at private pharmacies in Vietnam, The Annuals of Pharmacotherapy 35 (2001), 1283-1288.
8. Dong et al., Association between health insurance and antibiotics prescribing in four counties in rural China, Health Policy 48 (1999), 29-45.
9. Dua et al., The use of antimicrobial drugs in Nagpur, India. A window on medical care in a developing country, Social Science and Medicine 38 (1994), 717-724.
10. L. Gilson et al., Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania, Lancet 350 (1997), 1805-1809.
11. J.M. Grimshaw and I.T. Russell, Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations, Lancet 342 (1993), 1317-1322.
12. J.E. Hadiyono, S. Suryawati, S.S. Danu, Sunartono and B. Santoso, Interactional group discussion: results of a controlled trial using a behavioural intervention to reduce the use of injections in public health facilities, Soc. Sci. Med. 42 (1996), 1177-1183.
13. L.A. Lipsky and C.A. Taylor, The opinions and experiences of family physicians regarding direct-to-consumer advertising, Journal of Family Practice 45 (1997), 495-499.
14. Little et al., Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media, BMJ 322 (2001), 336-342.
15. Mills et al., What can be done about the private health sector in low-income countries?, Bulletin of the World Health Organization 80 (2002), 325-330.
16. A. Radyowijati and H. Haak, Determinants of antimicrobial use in the developing world, USAID, Bureau of Global Health, The Child Health Research Project Special Report, 2002.
17. L. Sachs and G. Tomson, Medicines and culture - a double perspective on drug utilisation in a developing country, Social Science and Medicine 34 (1992), 307-315.
18. B. Santoso, S. Suryawati and J.E. Prawaitasari, Small group intervention vs formal seminar for improving appropriate drug use, Soc. Sci. Med. 42 (1996), 1163-1168. Erratum in: Soc. Sci. Med. 43 (1996), I.
19. R. Smith, R. Beaglehole, D. Woodward and N. Drager, Global Public Goods for Health, Oxford University Press, 2003.
20. H. Standings, An overview of changing agendas in health sector reforms, Reproductive Health Matters 20 (2002), 19-28.
21. H. Standings, WHO, Health systems: improving performance. World Health Report, 2000.
22. S. Van der Geest and S.R. Whyte, The Context of Medicines in Developing Countries, Kluwer Academic Publishers, 1988.
23. G. Velásquez, Y. Madrid and J. Quick, Health Reform and Drug Financing: Selected Topic-Health Economics and Drugs, DAP Series No. 6, WHO/DAP/98.3, action programme on essential drugs, WHO, Geneva, 1998.
24. M. Whitehead, G. Dahlgren and T. Evans, Equity and health sector reforms: can low-income countries escape the medical poverty trap?, Lancet 358 (2001), 833-836.
25. S.R. Whyte, S. Van Der Geest and A. Hardon, Social lives of Medicines, Cambridge University Press, 2002.
26. WHO-EMRO, Agenda item 11(a): 'Antimicrobial resistance and rational use of Antimicrobial agents', WHO website: www.int/medicines/organization/par/ cd_25th_anniversary/4-rational/amr.ppt. Accessed 30 June 2004, 49th Session of the Regional Committee for the Eastern Mediterranean; 30 September-3 October 2002, Cairo, Egypt.
27. WHO, Shaping the future, World Health Report, 2003.
28. WHO, WHO Global strategy for containment of antimicrobial resistance, WHO/CDC/CSR/DRS/2001.2, Geneva, 2001.